Status:
UNKNOWN
Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic
Lead Sponsor:
IRCCS Policlinico S. Donato
Conditions:
Covid19
Interstitial Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
The investigating group aims at performing an observational, prospective study that involves the evaluation of circulating biomarkers predictive of clinical evolution in patients suffering from COVID-...
Detailed Description
Study design This observational, prospective, monocentric study will make use of the recruitment of consecutive patients with COVID-19. Enrollment will last 6 months or, considering the desirable drop...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Positivity to the test for SARS-Cov-2
- Informed consent to enrollment in the study.
- For Intensive Care patients: entry into the intensive unit and / or endotracheal intubation for no more than 4 days.
- For patients in the COVID19 wards: home hospitalization or emergency room for no more than 4 days.
Exclusion
- Age less than 18 years
- Pregnant women
- Patients with malignant neoplasm, autoimmune diseases.
- Hospitalization as transfer from another hospital or other similar facility.
Key Trial Info
Start Date :
March 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
204 Patients enrolled
Trial Details
Trial ID
NCT04441502
Start Date
March 30 2020
End Date
December 31 2024
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Policlinico San Donato
San Donato Milanese, MI, Italy, 20097